Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES ASTRAZENECA PHARMA ZYDUS LIFESCIENCES/
ASTRAZENECA PHARMA
 
P/E (TTM) x 34.4 95.3 36.1% View Chart
P/BV x 5.8 22.7 25.6% View Chart
Dividend Yield % 0.6 0.3 197.2%  

Financials

 ZYDUS LIFESCIENCES   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
ASTRAZENECA PHARMA
Mar-23
ZYDUS LIFESCIENCES/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs4953,620 13.7%   
Low Rs3192,438 13.1%   
Sales per share (Unadj.) Rs170.3401.2 42.4%  
Earnings per share (Unadj.) Rs19.839.7 49.8%  
Cash flow per share (Unadj.) Rs26.946.2 58.2%  
Dividends per share (Unadj.) Rs6.0016.00 37.5%  
Avg Dividend yield %1.50.5 278.9%  
Book value per share (Unadj.) Rs173.0234.4 73.8%  
Shares outstanding (eoy) m1,012.2025.00 4,048.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.47.5 31.7%   
Avg P/E ratio x20.676.3 27.0%  
P/CF ratio (eoy) x15.165.5 23.1%  
Price / Book Value ratio x2.412.9 18.2%  
Dividend payout %30.340.3 75.3%   
Avg Mkt Cap Rs m412,14475,718 544.3%   
No. of employees `000NANA-   
Total wages/salary Rs m24,5642,591 948.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37410,030 1,718.6%  
Other income Rs m4,746261 1,818.4%   
Total revenues Rs m177,12010,291 1,721.2%   
Gross profit Rs m29,6771,249 2,376.3%  
Depreciation Rs m7,227163 4,444.6%   
Interest Rs m1,2996 20,619.0%   
Profit before tax Rs m25,8971,341 1,931.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,878348 1,688.6%   
Profit after tax Rs m20,019993 2,016.2%  
Gross profit margin %17.212.5 138.3%  
Effective tax rate %22.726.0 87.4%   
Net profit margin %11.69.9 117.3%  
BALANCE SHEET DATA
Current assets Rs m100,0829,359 1,069.3%   
Current liabilities Rs m55,2674,844 1,140.9%   
Net working cap to sales %26.045.0 57.7%  
Current ratio x1.81.9 93.7%  
Inventory Days Days5049 101.7%  
Debtors Days Days9439 239.0%  
Net fixed assets Rs m144,7762,061 7,023.2%   
Share capital Rs m1,01250 2,024.0%   
"Free" reserves Rs m174,1465,811 2,996.7%   
Net worth Rs m175,1585,861 2,988.4%   
Long term debt Rs m00-   
Total assets Rs m244,94011,421 2,144.7%  
Interest coverage x20.9213.9 9.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 80.1%   
Return on assets %8.78.7 99.5%  
Return on equity %11.416.9 67.5%  
Return on capital %15.523.0 67.5%  
Exports to sales %39.20-   
Imports to sales %11.937.4 31.9%   
Exports (fob) Rs m67,577NA-   
Imports (cif) Rs m20,5443,747 548.3%   
Fx inflow Rs m67,577612 11,042.0%   
Fx outflow Rs m20,5443,747 548.3%   
Net fx Rs m47,033-3,135 -1,500.3%   
CASH FLOW
From Operations Rs m26,888583 4,612.8%  
From Investments Rs m11,712181 6,467.1%  
From Financial Activity Rs m-44,004-245 17,975.5%  
Net Cashflow Rs m-5,338519 -1,028.1%  

Share Holding

Indian Promoters % 75.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 18.0 5.4 332.7%  
FIIs % 5.0 2.7 187.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.1%  
Shareholders   306,495 29,032 1,055.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs ASTRAZENECA PHARMA Share Price Performance

Period Cadila Healthcare ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 1.06% -0.14% 1.30%
1-Month 8.30% -3.75% -0.64%
1-Year 108.55% 58.97% 62.00%
3-Year CAGR 32.51% 20.44% 18.20%
5-Year CAGR 24.65% 22.15% 19.81%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.